SFX by Ex Libris Inc.

Title:	Nuclear receptors in cancer — uncovering new and evolving roles through genomic analysis
Source:	Nature Reviews Genetics [1471-0056] Dhiman, Vineet yr:2017

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Doan, Tram B. "Emerging functional roles of nuclear receptors in breast cancer." Journal of molecular endocrinology 58.3 (2017).
description	2.	Kelloff, Gary J. "Cancer biomarkers: selecting the right drug for the right patient." Nature reviews. Drug discovery 11.3 (2012): 201-214.
description	3.	Gong, H. "Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase." Cancer research 68.18 (2008): 7386-93.
description	4.	Callewaert, L. "Interplay between two hormone-independent activation domains in the androgen receptor." Cancer research 66.1 (2006): 543-53.
description	5.	Alymani, Russell A. "Predictive biomarkers for personalised anti-cancer drug use: Discovery to clinical implementation." European journal of cancer 46.5 (2010): 869-879.
description	6.	"-/Carboxyl-terminal Interactions in Androgen Receptor Dimerization Revealed by Mutations That Cause Androgen Insensitivity." Journal of biological chemistry. 273.1: 92-101.
description	7.	Ferlay, J. "Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012." International journal of cancer 136.5 (2014): 359-86.
description	8.	Glass, Christopher K. "Signaling by nuclear receptors." Cold Spring Harbor perspectives in biology 5.3 (2013).
description	9.	Lamont, Kristin R. "Minireview: Alternative Activation Pathways for the Androgen Receptor in Prostate Cancer." Molecular endocrinology 25.6 (2011): 897-907.
description	10.	Yap, T. "Envisioning the future of early anticancer drug development." Nature Reviews. Cancer 10.7 (2010): 514-523.
description	11.	Eckelman, W. "Targeted imaging: an important biomarker for understanding disease progression in the era of personalized medicine." Drug discovery today 13.17-18 (2008): 748-759.
description	12.	Klein, Kenneth W W. "Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses." Science 321.5897 (2008): 1801-1806.
description	13.	Fresno Vara, Juan Angel A. "PI3K/Akt signalling pathway and cancer." Cancer treatment reviews 30.2 (2004): 193-204.
description	14.	Ito, H. "PI3K-Akt pathway: its functions and alterations in human cancer." Apoptosis 9.6 (2004): 667-676.
description	15.	Tekleab, D Williams W. "An Integrated Genomic Analysis of Human Glioblastoma Multiforme." Science 321.5897 (2008): 1807-1812.
description	16.	Ferlay, J. "Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008." International journal of cancer 127.12 (2010): 2893-2917.
description	17.	Torre, Lindsey A. "Global cancer statistics, 2012." Ca 65.2 (2015): 87-108.
description	18.	Siegel, R. "Cancer Statistics, 2014." Ca 64.1 (2014): 9-29.
description	19.	Ferlay, J. "Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012." European journal of cancer 49.6 (2013): 1374-1403.
description	20.	Gibbs, G. "Comprehensive genomic characterization defines human glioblastoma genes and core pathways." Nature 455.7216 (2008): 1061-8.